Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 5 of 5 entries
View as:

Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.

Phase: N/A Priority: Normal
NCT ID: NCT00056550 Org: User:
Start: 12/31/02 End: 02/29/04 Due: 02/28/05

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

Phase: N/A Priority: Normal
NCT ID: NCT01708564 Org: User:
Start: 10/31/12 End: 06/30/13 Due: 06/30/14

Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT02020369 Org: User:
Start: 04/30/14 End: 08/31/15 Due: 08/31/16

Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery

Phase: N/A Priority: Normal
NCT ID: NCT00110513 Org: User:
Start: 04/30/05 End: 07/31/08 Due: 07/31/09

Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia

Phase: N/A Priority: Normal
NCT ID: NCT02059135 Org: User:
Start: 07/11/14 End: 11/30/16 Due: 11/30/17